FOI disclosure log

FOI 5067 – PBAC's consideration of Nurtec

This FOI request is for correspondence regarding the Public Summary Documents of the Pharmaceutical Benefits Advisory Committee (PBAC) consideration of Pfizer's Nurtec (rimegepant) since July 2023.